Omada Health Reports Q3 Revenue of $91 Million, Raises 2026 Guidance
Omada posted $7 million in net income versus a $3 million year-earlier loss, while adjusted EBITDA rose to $12 million from $2 million. Members increased 36% year over year to 1.1 million; full-year revenue guidance is now $344 million to $346 million.
Omada Health announced its financial results for the third quarter ended September 30, 2026, reporting revenue of $91 million, which surpassed the FactSet consensus estimate of $85.6 million. The company achieved a net income of $7 million, a significant improvement compared to a net loss of $3 million in the same period last year. Adjusted EBITDA reached $12 million, up from $2 million in Q3 2025. Additionally, the company reported a 36% year-over-year increase in total members to 1.1 million and raised its full-year 2026 revenue guidance to a range of $344 million to $346 million.